Related Experiment Video
Updated: Jun 26, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
(G)Patching up mis-splicing in cancer
Maciej Cieśla1, Cristian Bellodi2
1IMol Polish Academy of Sciences, Warsaw, Poland.
Abstract:
Benbarche, Pineda, Galvis, et al. delineate an essential role for the G-patch motif-containing protein GPATCH8 in mis-splicing associated with cancer-driving mutations of the splicing factor SF3B1. GPATCH8 cooperates with SF3B1 mutants, affecting the splicing machinery. Targeting GPATCH8 reveals therapeutic opportunities for SF3B1 mutant cancers and other splicing-related diseases.
Insights
The G-patch motif protein GPATCH8 is crucial in cancer-driving mutations of the splicing factor SF3B1. Targeting GPATCH8 offers new therapeutic strategies for SF3B1 mutant cancers and splicing-related diseases.
Area of Science:
- Molecular Biology
- Cancer Genetics
- RNA Splicing
Background:
- Mutations in the splicing factor SF3B1 are common in various cancers.
- Aberrant RNA splicing contributes to cancer development and progression.
Purpose of the Study:
- To investigate the role of GPATCH8 in SF3B1-mutant cancers.
- To explore GPATCH8 as a potential therapeutic target.
Main Methods:
- Utilized molecular biology techniques to study protein interactions.
- Analyzed splicing patterns in cancer cell lines with SF3B1 mutations.
Main Results:
- GPATCH8 cooperates with mutant SF3B1, leading to aberrant splicing.
- GPATCH8 is essential for the mis-splicing phenotype in SF3B1-mutant cancers.
Conclusions:
- GPATCH8 plays a critical role in the pathogenesis of SF3B1-mutant cancers.
- Targeting GPATCH8 presents a promising therapeutic avenue for these cancers and other splicing-related disorders.
Related Concept Videos
Long-patch Base Excision Repair
Fixing Double-strand Breaks
Mismatch Repair
RNA Splicing
Nucleotide Excision Repair
Base Excision Repair
The first step of...

